John Laffey

MD, FCAI, MA

Co-Director, Critical Illness and Injury Research Centre

Biography

Dr. Laffey is Anesthesiologist-in-Chief at St Michael’s Hospital, Toronto, Co-Director of the Critical Illness and Injury Research Centre at the Keenan Research Centre, St. Michael’s hospital. He is a Clinician Scientist at the Keenan Research Centre, and Professor of Anesthesia, Critical Care and Physiology at the University of Toronto. His research is focused on ARDS, particularly the mechanisms underlying ventilation induced lung injury. He has a longstanding interest in the effects and mechanisms of hypercapnic acidosis in ARDS and sepsis. His current research focus is the investigation of the therapeutic potential of cell therapies for ARDS.

Recent Publications

  1. Grassi, A, Foti, G, Laffey, JG, Bellani, G. Noninvasive mechanical ventilation in early acute respiratory distress syndrome. 2017; :. doi: 10.20452/pamw.4088. PubMed PMID:28820175 .
  2. Jaber, S, Bellani, G, Blanch, L, Demoule, A, Esteban, A, Gattinoni, L et al.. The intensive care medicine research agenda for airways, invasive and noninvasive mechanical ventilation. Intensive Care Med. 2017; :. doi: 10.1007/s00134-017-4896-8. PubMed PMID:28785882 .
  3. Brodie, D, Curtis, JR, Vincent, JL, Bakker, J, Brown, CE, Creteur, J et al.. Treatment limitations in the era of ECMO. Lancet Respir Med. 2017; :. doi: 10.1016/S2213-2600(17)30263-1. PubMed PMID:28705688 .
  4. de Prost, N, Pham, T, Carteaux, G, Mekontso Dessap, A, Brun-Buisson, C, Fan, E et al.. Etiologies, diagnostic work-up and outcomes of acute respiratory distress syndrome with no common risk factor: a prospective multicenter study. Ann Intensive Care. 2017;7 (1):69. doi: 10.1186/s13613-017-0281-6. PubMed PMID:28631088 PubMed Central PMC5476531.
  5. Laffey, JG, Madotto, F, Bellani, G, Pham, T, Fan, E, Brochard, L et al.. Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study. Lancet Respir Med. 2017;5 (8):627-638. doi: 10.1016/S2213-2600(17)30213-8. PubMed PMID:28624388 .
  6. Curley, GF, Jerkic, M, Hogan, G, Masterson, C, O'Toole, D, Devaney, J et al.. The authors reply. Crit. Care Med. 2017;45 (7):e737-e738. doi: 10.1097/CCM.0000000000002480. PubMed PMID:28622234 .
  7. Laffey, JG, Matthay, MA. Fifty Years of Research in ARDS. Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value. Am. J. Respir. Crit. Care Med. 2017;196 (3):266-273. doi: 10.1164/rccm.201701-0107CP. PubMed PMID:28306336 PubMed Central PMC5549868.
  8. Bellani, G, Madotto, F, Pham, T, Fan, E, Laffey, JG. Reply: "Could Noninvasive Ventilation Failure Rates Be Underestimated in the LUNG SAFE Study?" and "High-Flow Oxygen, Positive End-Expiratory Pressure, and the Berlin Definition of Acute Respiratory Distress Syndrome: Are They Mutually Exclusive?". Am. J. Respir. Crit. Care Med. 2017;196 (3):397-398. doi: 10.1164/rccm.201702-2565LE. PubMed PMID:28231018 .
  9. Vargas, M, Pastore, A, Aloj, F, Laffey, JG, Servillo, G. A comparison of videolaryngoscopes for tracheal intubation in predicted difficult airway: a feasibility study. BMC Anesthesiol. 2017;17 (1):25. doi: 10.1186/s12871-017-0318-2. PubMed PMID:28219331 PubMed Central PMC5319085.
  10. Dreyfuss, D, Gaudry, S, Madotto, F, Laffey, JG. Some remaining important questions after LUNG SAFE : Discussion of "Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study". Intensive Care Med. 2017;43 (4):598-599. doi: 10.1007/s00134-017-4706-3. PubMed PMID:28213623 .
Search PubMed

Affiliations & Other Activities

  • Scientist, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital
  • Chief, Department of Anesthesia, St. Michael’s Hospital
  • Professor, Anesthesia, Critical Care, and Physiology, University of Toronto
X